查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1652157

对比注射器市场评估（按产品类型、应用、最终用户、地区、机会和预测），2018 年至 2032 年

Contrast Media Injectors Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 225 Pages | 商品交期: 3-5个工作天内

价格

全球造影剂注射器市场预计将从 2024 年的 15.1 亿美元成长到 2032 年的 28.5 亿美元，在 2025-2032 年预测期内的复合年增长率为 8.25%。市场成长的动力包括慢性病盛行率上升、投资增加、技术进步以及诊断影像程序的增加。推动成长的其他因素包括对微创手术的需求、医疗保健支出的增加以及对早期诊断的认识的不断提高，尤其是在新兴国家。

造影剂注射器是一种医疗设备，用于将造影剂注入患者的循环系统，以提高所获取影像的诊断品质。利用它进行CT和MRI影像诊断，可以实现准确的诊断和有效的治疗计划。癌症、心血管疾病等慢性病的快速成长正在推动造影剂注射器市场的成长。这些疾病通常需要频繁且准确的影像才能有效治疗，从而增加了对包括造影剂注射器在内的先进诊断工具的需求。这一趋势凸显了造影剂注射器在改善影像能力以及进而改善患者治疗效果方面的重要作用。

此外，製造商越来越注重策略联盟，以改善注射器技术，满足医疗保健提供者和患者日益增长的需求。例如，2023 年 11 月，Bracco Imaging S.p.A. 宣布与 Ulrich GmbH & Co. KG 建立长期合作，后者是一家以造影剂注射器和脊椎植入物而闻名的德国医疗器材公司。透过此次合作，Bracco 计划根据自有品牌协议将其先进的 MR 注射器引入美国。此类合作关係将透过促进创新和技术开拓，对造影剂注射器市场的成长产生重大影响。此外，这种合作关係加强了医疗器材製造商的市场地位，使他们能够提供新的尖端解决方案以保持竞争力。

目录

第 1 章 专案范围与定义

第 2 章 研究方法

第 3 章执行摘要

第

4 章2018 年至 2032 年全球造影剂注射器市场展望

  • 市场规模分析及预测
    • 按金额
    • 按数量
  • 市占率分析及预测
    • 依产品类型
      • 喷射系统
      • 消耗品
      • 配件
    • 依用途
      • 放射科
      • 介入性心臟病学
      • 介入性放射学
    • 按最终用户
      • 医院
      • 门诊手术中心
      • 诊断影像中心
      • 其他
    • 按地区
      • 北美洲
      • 欧洲 亚太地区
      • 南美洲
      • 中东和非洲
    • 依公司分析市场占有率（前 5 名及其他 - 按价值，2024 年）
  • 2024 年市场地图分析
    • 依产品类型
    • 依用途
    • 按最终用户
    • 按地区

第 5 章2018 年至 2032 年北美造影剂注射器市场展望*

  • 市场规模分析及预测
    • 按金额
    • 按数量
  • 市占率分析及预测
    • 依产品类型
      • 喷射系统
      • 消耗品
      • 配件
    • 依用途
      • 放射科
      • 介入性心臟病学
      • 介入性放射学
    • 按最终用户
      • 医院
      • 门诊手术中心
      • 诊断影像中心
      • 其他
    • 国家占有率
      • 美国
      • 加拿大
      • 墨西哥
  • 国家市场评估
    • 2018 年至 2032 年美国造影剂注射器市场展望*
      • 市场规模分析及预测
      • 市占率分析及预测
    • 加拿大
    • 墨西哥

所有市场区隔均提供各对地区与国家。

第6章 2018 年至 2032 年欧洲造影剂注射器市场展望

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙
  • 波兰

第 7 章 2018-2032 年亚太地区造影剂注射器市场展望

  • 印度
  • 中国
  • 日本
  • 澳大利亚 越南
  • 韩国
  • 印尼
  • 菲律宾

第 8 章2018 年至 2032 年南美洲造影剂注射器市场展望

  • 巴西
  • 阿根廷

第 9 章2018 年至 2032 年中东和非洲造影剂注射器市场展望

  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 南非
  • 以色列

第 10 章 需求与供给分析

第11章 进出口分析

第 12 章 价值链分析

第 13 章 波特五力分析

第 14 章 PESTLE 分析

第 15 章 定价分析

第 16 章 市场动态

  • 市场推动因素
  • 市场课题

第 17 章 市场趋势与发展

第 18 章 监理架构与创新

  • 发展与创新
  • 监理机关核准

第 19 章：专利格局

第 20 章个案研究

第 21 章 竞争格局

  • 五大市场领导者的竞争矩阵
  • 前 5 家公司的 SWOT 分析
  • 市场前 10 大公司现状
    • 拜耳公司
      • 公司简介
      • 主要管理团队
      • 产品与服务
      • 财务表现（如报告）
      • 主要市场重点与地理分布
      • 近期发展/合作/伙伴关係/合併与收购
    • Ulrich GmbH &Co. KG
    • Bracco Imaging SpA
    • Medtron AG
    • Nemoto Kyorindo Co., Ltd.
    • Guerbet, LLC
    • Mallinckrodt plc
    • Sino Medical-Device Technology Co., Ltd.（Sinomdt）
    • APOLLO RT Co. Ltd.
    • Shenzhen Seacrown Electromechanical Co., Ltd.

上述公司不依市场占有率排序，并且可能会根据研究工作期间获得的资讯进行更改。

第 22 章 策略建议

第 23 章 关于研究公司/免责声明

Product Code: MX12724

Global contrast media injectors market is projected to witness a CAGR of 8.25% during the forecast period 2025-2032, growing from USD 1.51 billion in 2024 to USD 2.85 billion in 2032. The market growth is supported by the growing incidence of chronic diseases, rising investments, technological advances, and increasing diagnostic imaging procedures. Other factors include demand for minimally invasive surgeries, rising healthcare expenditure, and growing awareness regarding early diagnosis, especially among emerging economies.

Contrast media injectors are medical equipment designed to administer contrast agents in the patient's circulatory system to enhance the diagnostic quality of the images acquired. Such injectors ensure accurate diagnosis and efficient planning of the treatment when employed in CT and MRI imaging techniques. A tremendous rise in chronic diseases, such as cancer and cardiovascular diseases, has increased market growth for contrast media injectors. Since these diseases often require frequent and precise imaging for effective management, the demand for advanced diagnostic tools, including contrast media injectors, is increasing. This trend highlights these devices' essential role in improving patient outcomes by providing enhanced imaging capabilities.

Furthermore, manufacturing companies are increasingly focusing on strategic collaborations to improve injector technologies to cater to increasing demand by both healthcare providers and patients. For instance, in November 2023, Bracco Imaging S.p.A. announced a long-term partnership with Ulrich GmbH & Co. KG, a German medical devices company known for its contrast media injectors and spinal implants. Through the partnership, Bracco aims to introduce an advanced MR injector into the United States under a private-label agreement. Such partnerships significantly impact market growth for contrast media injectors through the promotion of innovation and technological development. Moreover, these partnerships strengthen the position of medical device manufacturers in the market so that they can offer new, state-of-the-art solutions to remain competitive.

Rising Demand of Contrast Media Injectors in the Pharmaceutical Industry

The growing demand for contrast media injectors is boosted due to immense advancements that enhance precision in delivering contrast agents, thus making these injectors very valuable in diverse medical procedures. These technological improvements, such as automated systems with incorporated imaging, real-time monitoring, and user-friendly interfaces, ensure contrast agents' safe and efficient administration. Such advancements further improve the accuracy of diagnoses and ensure patient safety, leading to their widespread application in healthcare. Manufacturers are focusing on meeting the rising demand for injector technology and making it ever-evolving through research and development, strategic collaborations, and integration of high technologies. This research caters to the growing market demand and makes the growing contrast media injectors market expand the scope of companies in terms of competitiveness between medical device manufacturing companies. For instance, in December 2024, Bracco Diagnostics Inc., a subsidiary of Bracco Imaging S.p.A received FDA 510(k) clearance for their Max 3, a syringeless MRI injector that eliminates waste from plastic syringes and injects directly from original vials. It is an eco-friendly product that promotes sustainable practices, significantly progressing the contrast media injectors market by further strengthening medical device manufacturers' technological and market positions.

Growing Investments Support Market Expansion

Investment in healthcare infrastructure from the public and private sectors is rising. These growing investments are supporting the contrast media injectors market expansion. Funding and government grants for cutting-edge medical technologies facilitate the development and implementation of contrast media injectors, improving market growth. For instance, in November 2024, the UK government promised new funding to see the NHS deliver an additional two million operations, scans, and appointments yearly to slash waiting lists and times in England by immense proportions. This allocation comprises USD 88 million for new radiotherapy machines. Contrast media helps with internal body images during such procedures as CT, MRI, X-ray, or ultrasound examinations. NHS Shared Business Services (SBS) has updated its contrast media framework agreement. This NHS SBS's Contrast Media framework agreement includes two categories: contrast media, injectors, and associated products. It will run until March 25, 2028. This will provide enormous opportunities for contrast media injectors. Such government efforts will lead to increased investment in and the development of technology in the contrast media injectors market.

Hospital Segment Account for a Significant Share of the Market

The hospital segment dominates the contrast media injectors market majorly because there is always a high number of patient footfalls in hospitals for diagnostic imaging procedures like CT, MRI, and angiography. Hospitals have the infrastructure and experienced radiologists and technicians. This segment benefits from the combined purchasing of injectors, contrast agents, and accessories- resulting in cost-effectiveness and minimizing operational interruptions. Moreover, there is an augmented prevalence of chronic diseases related to cancer and cardiovascular disorders that led to increased MRI and CT scans in hospital facilities, further led to the demand for contrast media injectors in hospitals. Furthermore, large-sized hospitals engage in clinical trials and research and embrace new technologies quicker than others. Increasing numbers of multi-specialty hospitals globally are further boosting this category. For example, in April 2024, Damani Multi Super Specialty Hospital in Mumbai announced to increase its capacity by 1,000 beds, which is being established with an investment of almost USD 72 million. This project will strengthen this region's healthcare infrastructure on a massive scale while taking care of increasing demand, thereby improving healthcare services. All these factors and ongoing developments in imaging technologies ensure that hospitals remain the most preferable place to utilize contrast media injectors.

North America Holds Major Market Share

North America holds a considerable share of the contrast media injectors market due to the well-established healthcare infrastructure, including hospitals, diagnostic imaging centers, and research institutions that frequently use these injectors for high-resolution imaging. The region's high healthcare expenditure, such as that of the United States, supports adopting advanced medical technologies. The favorable insurance and reimbursement policies support contrast media injectors in healthcare institutions. With continual innovations in automated and dual-head injectors, medical imaging technology leadership in North America improves diagnostic accuracy and facilitates greater patient protection. The rising incidence of chronic diseases among the aging population necessitates frequent imaging procedures, increasing the demand for these injectors. The National Cancer Institute estimates 2,001,140 new cancer cases in the United States in 2024. In addition, government healthcare policies with a robust reimbursement system and manufacturers' efforts to increase their product offerings through new products launched in the United States market help grow the market and attract investments and technology into the contrast media injectors market.

Future Market Scenario (2025 - 2032F)

According to the market analysis, the contrast media injectors market is poised for tremendous growth, with rising demand for technologically advanced solutions and minimally invasive procedures. Other drivers include higher investments in health care in emerging economies, increased prevalence of chronic diseases, and automation improvements in injectors that improve the safety and efficiency of medical procedures. The market will benefit in the coming years due to integrating innovative technologies and personalized dosing solutions that optimize imaging quality and reduce waste. Government support for healthcare infrastructure through various initiatives will stimulate demand for advanced diagnostic tools; hence, this sector presents plenty of growth opportunities.

Moreover, the leading players focus on innovative product launches, which provides a paramount opportunity in contrast to the media injectors market. For instance, in November 2024, Bayer AG received FDA approval for the MEDRAD Centargo CT Injection System, which enhances workflow efficiency. Since its 2020 CE approval, it has been available in 49 markets and helps address the US's radiology technologist shortage and growing imaging demand. It integrates with Bayer's imaging and workflow solutions to enhance patient care, reduce administrative burdens, and optimize contrast usage in high-volume CT suites.

Key Players Landscape and Outlook

Innovative product launches, strategic global expansions, and key collaborations are helping the leading companies, in contrast, media injectors market strengthen their presence globally and capture market share. These are helping advance technologies, fortify their position in the marketplace, and expand their reach in the global healthcare arena.

In December 2024, Bayer AG presented new developments within its radiology portfolio, including AI inventions, at the Radiological Society of North America (RSNA) Annual Meeting. The company released new data on gadoquatrane, a Phase III low-dose gadolinium-based contrast agent, and its FDA-cleared MEDRAD Centargo CT Injection System. It also expanded seven new AI-enabled collaboration agreements to its Calantic Digital Solutions platform to enhance its leadership in the radiology and contrast media injectors market.

In October 2024, Ulrich GmbH & Co. KG achieved a significant milestone by establishing a Spanish subsidiary. It will operate in a market that holds 30% of its market share. The newly formed subsidiary directly undertakes sales and supports tapping the existing potential. Combining Ulm's experience with the knowledge of the Spanish team, the expansion will push forward and further consolidate Ulrich's position in the European market.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Contrast Media Injectors Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product Type
      • 4.2.1.1. Injector Systems
        • 4.2.1.1.1. Single-Head Injectors
        • 4.2.1.1.2. Dual-Head Injectors
        • 4.2.1.1.3. Syringeless Injectors
      • 4.2.1.2. Consumables
        • 4.2.1.2.1. Injector Heads
        • 4.2.1.2.2. Syringes
        • 4.2.1.2.3. Tubing
        • 4.2.1.2.4. Other Consumables
      • 4.2.1.3. Accessories
    • 4.2.2. By Application
      • 4.2.2.1. Radiology
        • 4.2.2.1.1. CT Imaging
        • 4.2.2.1.2. MRI Imaging
        • 4.2.2.1.3. X-ray Imaging
      • 4.2.2.2. Interventional Cardiology
      • 4.2.2.3. Interventional Radiology
    • 4.2.3. By End-user
      • 4.2.3.1. Hospitals
      • 4.2.3.2. Ambulatory Surgery Centers
      • 4.2.3.3. Diagnostic Imaging Centers
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia-Pacific
      • 4.2.4.4. South America
      • 4.2.4.5. Middle East and Africa
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Product Type
    • 4.3.2. By Application
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. North America Contrast Media Injectors Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product Type
      • 5.2.1.1. Injector Systems
        • 5.2.1.1.1. Single-Head Injectors
        • 5.2.1.1.2. Dual-Head Injectors
        • 5.2.1.1.3. Syringeless Injectors
      • 5.2.1.2. Consumables
        • 5.2.1.2.1. Injector Heads
        • 5.2.1.2.2. Syringes
        • 5.2.1.2.3. Tubing
        • 5.2.1.2.4. Other Consumables
      • 5.2.1.3. Accessories
    • 5.2.2. By Application
      • 5.2.2.1. Radiology
        • 5.2.2.1.1. CT Imaging
        • 5.2.2.1.2. MRI Imaging
        • 5.2.2.1.3. X-ray Imaging
      • 5.2.2.2. Interventional Cardiology
      • 5.2.2.3. Interventional Radiology
    • 5.2.3. By End-user
      • 5.2.3.1. Hospitals
      • 5.2.3.2. Ambulatory Surgery Centers
      • 5.2.3.3. Diagnostic Imaging Centers
      • 5.2.3.4. Others
    • 5.2.4. By Country Share
      • 5.2.4.1. United States
      • 5.2.4.2. Canada
      • 5.2.4.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Contrast Media Injectors Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product Type
          • 5.3.1.2.1.1. Injector Systems
          • 5.3.1.2.1.1.1. Single-Head Injectors
          • 5.3.1.2.1.1.2. Dual-Head Injectors
          • 5.3.1.2.1.1.3. Syringeless Injectors
          • 5.3.1.2.1.2. Consumables
          • 5.3.1.2.1.2.1. Injector Heads
          • 5.3.1.2.1.2.2. Syringes
          • 5.3.1.2.1.2.3. Tubing
          • 5.3.1.2.1.2.4. Other Consumables
          • 5.3.1.2.1.3. Accessories
        • 5.3.1.2.2. By Application
          • 5.3.1.2.2.1. Radiology
          • 5.3.1.2.2.1.1. CT Imaging
          • 5.3.1.2.2.1.2. MRI Imaging
          • 5.3.1.2.2.1.3. X-ray Imaging
          • 5.3.1.2.2.2. Interventional Cardiology
          • 5.3.1.2.2.3. Interventional Radiology
        • 5.3.1.2.3. By End-user
          • 5.3.1.2.3.1. Hospitals
          • 5.3.1.2.3.2. Ambulatory Surgery Centers
          • 5.3.1.2.3.3. Diagnostic Imaging Centers
          • 5.3.1.2.3.4. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Contrast Media Injectors Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Contrast Media Injectors Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Contrast Media Injectors Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Contrast Media Injectors Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Developments and Innovations
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Bayer AG
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. Ulrich GmbH & Co. KG
    • 21.3.3. Bracco Imaging S.p.A
    • 21.3.4. Medtron AG
    • 21.3.5. Nemoto Kyorindo Co., Ltd.
    • 21.3.6. Guerbet, LLC
    • 21.3.7. Mallinckrodt plc
    • 21.3.8. Sino Medical-Device Technology Co., Ltd. (Sinomdt)
    • 21.3.9. APOLLO RT Co. Ltd.
    • 21.3.10. Shenzhen Seacrown Electromechanical Co., Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 2. Global Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 3. Global Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 4. Global Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 5. Global Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Contrast Media Injectors Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 8. North America Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 9. North America Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 10. North America Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 11. North America Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 12. North America Contrast Media Injectors Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 14. United States Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 15. United States Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 16. United States Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 17. United States Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 18. Canada Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 19. Canada Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 20. Canada Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 21. Canada Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 22. Canada Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 23. Mexico Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 24. Mexico Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 25. Mexico Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 26. Mexico Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 27. Mexico Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 28. Europe Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 29. Europe Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 30. Europe Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 31. Europe Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 32. Europe Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 33. Europe Contrast Media Injectors Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 35. Germany Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 36. Germany Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 37. Germany Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 38. Germany Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 39. France Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 40. France Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 41. France Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 42. France Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 43. France Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 44. Italy Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 45. Italy Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 46. Italy Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 47. Italy Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 48. Italy Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 49. United Kingdom Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 50. United Kingdom Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 51. United Kingdom Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 52. United Kingdom Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 53. United Kingdom Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 54. Russia Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 55. Russia Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 56. Russia Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 57. Russia Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 58. Russia Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 59. Netherlands Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 60. Netherlands Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 61. Netherlands Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 62. Netherlands Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 63. Netherlands Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 64. Spain Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 65. Spain Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 66. Spain Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 67. Spain Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 68. Spain Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 69. Turkey Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 70. Turkey Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 71. Turkey Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 72. Turkey Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 73. Turkey Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 74. Poland Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 75. Poland Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 76. Poland Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 77. Poland Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 78. Poland Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 79. South America Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 80. South America Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 81. South America Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 82. South America Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 83. South America Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 84. South America Contrast Media Injectors Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 86. Brazil Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 87. Brazil Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 88. Brazil Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 89. Brazil Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 90. Argentina Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 91. Argentina Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 92. Argentina Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 93. Argentina Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 94. Argentina Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 95. Asia-Pacific Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 97. Asia-Pacific Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 98. Asia-Pacific Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 99. Asia-Pacific Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 100. Asia-Pacific Contrast Media Injectors Market Share (%), By Country, 2018-2032F
  • Figure 101. India Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 102. India Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 103. India Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 104. India Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 105. India Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 106. China Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 107. China Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 108. China Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 109. China Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 110. China Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 111. Japan Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 112. Japan Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 113. Japan Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 114. Japan Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 115. Japan Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 116. Australia Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 117. Australia Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 118. Australia Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 119. Australia Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 120. Australia Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 121. Vietnam Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 122. Vietnam Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 123. Vietnam Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 124. Vietnam Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 125. Vietnam Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 126. South Korea Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 127. South Korea Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 128. South Korea Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 129. South Korea Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 130. South Korea Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 131. Indonesia Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 132. Indonesia Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 133. Indonesia Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 134. Indonesia Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 135. Indonesia Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 136. Philippines Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 137. Philippines Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 138. Philippines Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 139. Philippines Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 140. Philippines Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 141. Middle East & Africa Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 143. Middle East & Africa Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 144. Middle East & Africa Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 145. Middle East & Africa Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 146. Middle East & Africa Contrast Media Injectors Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 149. Saudi Arabia Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 150. Saudi Arabia Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 151. Saudi Arabia Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 152. UAE Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 153. UAE Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 154. UAE Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 155. UAE Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 156. UAE Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 157. South Africa Contrast Media Injectors Market, By Value, in USD Billion, 2018-2032F
  • Figure 158. South Africa Contrast Media Injectors Market, By Volume, in Thousand Units, 2018-2032F
  • Figure 159. South Africa Contrast Media Injectors Market Share (%), By Product Type, 2018-2032F
  • Figure 160. South Africa Contrast Media Injectors Market Share (%), By Application, 2018-2032F
  • Figure 161. South Africa Contrast Media Injectors Market Share (%), By End-user, 2018-2032F
  • Figure 162. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024